New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
11:05 EDTMEET, CACQ, VRSN, SIMG, IPXLHigh option volume stocks: SIMG CACQ IPXL VRSN MEET
News For SIMG;CACQ;IPXL;VRSN;MEET From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
11:07 EDTIPXLFTC approves Perrigo as buyer of CorePharma pilocarpine assets
Subscribe for More Information
April 23, 2015
16:45 EDTVRSNVeriSign sees FY15 revenue $1.043B-$1.057B, consensus $1.06B
Revenue guidance revised from previous $1.040B-$1.060B. Sees FY15 adjusted gross margin at least 80%. Sees FY15 adjusted operating margin 60%-62%. Guidance given during Q1 earnings conference call.
16:29 EDTVRSNVeriSign reports Q1 adjusted EPS 74c, consensus 75c
Subscribe for More Information
April 20, 2015
07:18 EDTIPXLAmerican Academy of Neurology to hold annual meeting
Subscribe for More Information
April 17, 2015
10:00 EDTIPXLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:58 EDTIPXLImpax downgraded to Sell from Neutral at UBS
UBS downgraded Impax Laboratories to Sell saying the risk/reward is biased to the downside following the recent rally in shares. UBS attributes the recent run-up in shares to expectations the company will do more deals or get acquired. The firm does not see either scenario driving the stock much above current levels "any time soon." It keeps a $36 price target for Impax shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use